Hjem › Kardiovaskulær sykdom › Washington
Kliniske studier for Kardiovaskulær sykdom i Washington
15 studier for Kardiovaskulær sykdom søker deltakere på steder i Washington.
Byer i Washington
Offisiell studietekst (engelsk)
ELEVATE-HFpEF Clinical Study
- Saint Joseph Medical Center (Tacoma WA), Tacoma
Rekrutterer
Alder 40 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06678841EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Universal Research Group, LLC, Tacoma
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07064473Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- MultiCare Institute for Research and Innovation, Puyallup
- MultiCare Institute for Research and Innovation, Tacoma
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06909565A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Eastside Research Associates, Redmond
RekruttererFase 3
Alder 45 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07613294Product Surveillance Registry
- Bremerton
- Seattle
- Spokane
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT01524276Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Bellevue
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT07181109Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- University of Washington (UW) Medical Center, Seattle
- Providence Sacred Heart Medical Center & Children's Hospital, Spokane
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT03242642An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Harborview Medical Center, Seattle
- Swedish Medical Center-Cardiovascular Research, Seattle
- Univ of Washington Medical Center, Seattle
RekruttererFase 3
Alder 18 til 100 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07517263A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
- Seattle Children's Hospital, Seattle
RekruttererObservasjonsstudie
Alder 7 og eldre · Alle kjønn · Oppdatert 25. aug. 2026 · NCT05705531A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Puyallup
- Research Site, Redmond
- Research Site, Renton
- og 2 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Western Washington Medical Group, Everett
- Rainier Clinical Research Center, Renton
RekruttererFase 3
Alder 50 til 105 · Alle kjønn · Oppdatert 21. aug. 2026 · NCT07136012Global Paradise System US Post Approval Study
- Swedish Medical Center, Seattle
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 12. aug. 2026 · NCT06297291PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Providence Everett, Everett
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jun. 2026 · NCT05934487Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 24. mar. 2026 · NCT06217302MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
RekruttererFase 1
Alder 12 til 25 · Alle kjønn · Oppdatert 13. jun. 2025 · NCT05065372Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.